Ann E. Weber
Kallyope (United States)(US)University of Bayreuth(DE)
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Peptidase Inhibition and Analysis, Diabetes Treatment and Management, Receptor Mechanisms and Signaling, Pharmacological Effects and Assays
Most-Cited Works
- → (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes(2004)814 cited
- → Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes(2005)490 cited
- → Asymmetric glycine enolate aldol reactions: synthesis of cyclosporin's unusual amino acid, MeBmt(1986)342 cited
- → Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy(2017)331 cited
- → Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes(2004)279 cited
- → Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides(2000)199 cited